Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705)

Hunan Jiudian Pharmaceutical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,840	2,691	2,325	1,627	975.71	920.85
Other Revenue	1	1.02	0.89	0.82	2.45	3.21
Revenue	2,841	2,693	2,326	1,628	978.16	924.06
Revenue Growth (YoY)	13.05%	15.75%	42.92%	66.40%	5.85%	15.31%
Cost of Revenue	718.72	621.79	522.52	365.47	253.29	302.45
Gross Profit	2,122	2,071	1,804	1,262	724.87	621.61
Selling, General & Admin	1,355	1,405	1,285	878.31	547.49	444.32
Research & Development	277.12	254.12	201.26	146.26	81.68	109.8
Other Operating Expenses	37.43	28.47	25.87	21.04	14.26	11.58
Operating Expenses	1,668	1,696	1,525	1,051	646.72	568.81
Operating Income	453.98	375.12	278.84	211.22	78.16	52.8
Interest Expense	-19.33	-11.06	-18.42	-16.01	-5.25	-4.68
Interest & Investment Income	8.72	7.67	6.8	5.82	0.84	0.73
Currency Exchange Gain (Loss)	-0.49	-0.42	-0.27	-0.14	-0.34	-0.15
Other Non Operating Income (Expenses)	-10.02	-0.29	-0.24	-0.19	-0.13	-0.11
EBT Excluding Unusual Items	432.86	371.02	266.71	200.7	73.28	48.59
Gain (Loss) on Sale of Assets	-	0.03	-	0.02	-	-0.12
Asset Writedown	-2.45	-1.46	-1.3	-1.9	-1.39	-3.3
Other Unusual Items	66.05	32.57	24.81	27.38	18.95	13.72
Pretax Income	496.46	402.16	290.22	226.19	90.84	58.9
Income Tax Expense	41.7	33.9	20.52	21.94	8.58	3.83
Earnings From Continuing Operations	454.76	368.26	269.7	204.25	82.26	55.07
Net Income	454.76	368.26	269.7	204.25	82.26	55.07
Net Income to Common	454.76	368.26	269.7	204.25	82.26	55.07
Net Income Growth	34.72%	36.54%	32.05%	148.29%	49.38%	-23.50%
Shares Outstanding (Basic)	482	482	460	461	461	469
Shares Outstanding (Diluted)	482	482	460	461	461	469
Shares Change (YoY)	2.78%	4.64%	-0.15%	0.12%	-1.89%	3.17%
EPS (Basic)	0.94	0.76	0.59	0.44	0.18	0.12
EPS (Diluted)	0.94	0.76	0.59	0.44	0.18	0.12
EPS Growth	31.08%	30.49%	32.24%	147.98%	52.26%	-25.85%
Free Cash Flow	285.91	4.37	-144.39	64.94	71.64	-91.25
Free Cash Flow Per Share	0.59	0.01	-0.31	0.14	0.16	-0.19
Dividend Per Share	0.229	0.229	0.169	0.133	0.022	0.018
Dividend Growth	36.00%	36.00%	26.67%	507.76%	19.02%	-23.33%
Gross Margin	74.70%	76.91%	77.54%	77.55%	74.11%	67.27%
Operating Margin	15.98%	13.93%	11.99%	12.98%	7.99%	5.71%
Profit Margin	16.01%	13.68%	11.59%	12.55%	8.41%	5.96%
Free Cash Flow Margin	10.06%	0.16%	-6.21%	3.99%	7.32%	-9.87%
EBITDA	533.44	444.32	338.49	264.8	126.39	90.15
EBITDA Margin	18.78%	16.50%	14.55%	16.27%	12.92%	9.76%
D&A For EBITDA	79.46	69.2	59.64	53.58	48.24	37.35
EBIT	453.98	375.12	278.84	211.22	78.16	52.8
EBIT Margin	15.98%	13.93%	11.99%	12.98%	7.99%	5.71%
Effective Tax Rate	8.40%	8.43%	7.07%	9.70%	9.45%	6.51%
Revenue as Reported	2,841	2,693	2,326	1,628	978.16	924.06
Advertising Expenses	-	73.01	77.41	28.51	1.8	8.46

Source: S&P Capital IQ. Standard template. Financial Sources.